Damon J Vidrine1, Summer G Frank2, Micah J Savin3, Andrew J Waters4, Yisheng Li5, Sixia Chen6, Faith E Fletcher7, Roberto C Arduino8, Ellen R Gritz9. 1. Department of Family and Preventive Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK. 2. The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK. 3. California State University San Marcos, San Marcos, CA. 4. Department of Medical and Clinical Psychology, Uniformed Services University of the Health Sciences, Bethesda, MD. 5. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. 6. Department of Biostatistics and Epidemiology, College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, OK. 7. Division of Community Health Sciences, School of Public Health, University of Illinois at Chicago, Chicago, IL. 8. Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX. 9. Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract
Introduction: Tobacco use among persons living with HIV represents an important risk factor for poor treatment outcomes, morbidity, and mortality. Thus, efforts designed to inform the development of appropriate smoking cessation programs for this population remains a public health priority. To address this need, a study was conducted to longitudinally assess the relationship between intention to quit smoking and cessation over the 12-month period following initiation of HIV care. Methods: Patients initiating HIV care at a large inner city safety net clinic were enrolled (n = 378) in a 12-month prospective study. Audio computer-assisted self-interviews were conducted at baseline, and at 3, 6, 9, and 12 months post-enrollment, and HIV-related clinical data were collected from participants' electronic medical records. Variables of interest included intention to quit smoking, 7-day point prevalence smoking abstinence (biochemically verified), and stage of HIV. Data were collected in Houston, Texas from 2009 to 2015. Results: The sample was 75% male and 62% Black. Findings indicated that intention to quit smoking increased between baseline and 3 months, and subsequently trended downward from 3 to 12 months. Results from linear and generalized linear mixed models indicated that participants with advanced HIV disease (vs. not advanced) reported significantly (p < .05) higher intention to quit smoking at 3, 6, and 12 months post-study enrollment. A similar though nonsignificant pattern was observed in the smoking abstinence outcome. Conclusions: HIV treatment initiation appears to be associated with increases in intention to quit smoking thus serves as a potential teachable moment for smoking cessation intervention. Implications: This study documents significant increases in intention to quit smoking in the 3-month period following HIV care initiation. Moreover, quit intention trended downward following the 3-month follow-up until the 12-month follow-up. In addition, a marked effect for HIV disease stage was observed, whereby participants with advanced HIV disease (vs. those without) experienced a greater increase in intention to quit. HIV treatment initiation appears to be associated with increases in intention to quit smoking, thus serves as a crucial teachable moment for smoking cessation intervention for people living with HIV.
Introduction: Tobacco use among persons living with HIV represents an important risk factor for poor treatment outcomes, morbidity, and mortality. Thus, efforts designed to inform the development of appropriate smoking cessation programs for this population remains a public health priority. To address this need, a study was conducted to longitudinally assess the relationship between intention to quit smoking and cessation over the 12-month period following initiation of HIV care. Methods: Patients initiating HIV care at a large inner city safety net clinic were enrolled (n = 378) in a 12-month prospective study. Audio computer-assisted self-interviews were conducted at baseline, and at 3, 6, 9, and 12 months post-enrollment, and HIV-related clinical data were collected from participants' electronic medical records. Variables of interest included intention to quit smoking, 7-day point prevalence smoking abstinence (biochemically verified), and stage of HIV. Data were collected in Houston, Texas from 2009 to 2015. Results: The sample was 75% male and 62% Black. Findings indicated that intention to quit smoking increased between baseline and 3 months, and subsequently trended downward from 3 to 12 months. Results from linear and generalized linear mixed models indicated that participants with advanced HIV disease (vs. not advanced) reported significantly (p < .05) higher intention to quit smoking at 3, 6, and 12 months post-study enrollment. A similar though nonsignificant pattern was observed in the smoking abstinence outcome. Conclusions: HIV treatment initiation appears to be associated with increases in intention to quit smoking thus serves as a potential teachable moment for smoking cessation intervention. Implications: This study documents significant increases in intention to quit smoking in the 3-month period following HIV care initiation. Moreover, quit intention trended downward following the 3-month follow-up until the 12-month follow-up. In addition, a marked effect for HIV disease stage was observed, whereby participants with advanced HIV disease (vs. those without) experienced a greater increase in intention to quit. HIV treatment initiation appears to be associated with increases in intention to quit smoking, thus serves as a crucial teachable moment for smoking cessation intervention for people living with HIV.
Authors: Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read Journal: Am J Public Health Date: 2010-08-19 Impact factor: 9.308
Authors: Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg Journal: J Acquir Immune Defic Syndr Date: 2006-09 Impact factor: 3.731
Authors: J Lee Westmaas; Christina C Newton; Victoria L Stevens; W Dana Flanders; Susan M Gapstur; Eric J Jacobs Journal: J Clin Oncol Date: 2015-04-20 Impact factor: 44.544
Authors: Marie Helleberg; Jan Gerstoft; Shoaib Afzal; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Stig E Bojesen; Børge G Nordestgaard; Niels Obel Journal: AIDS Date: 2014-06-19 Impact factor: 4.177
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: Line D Rasmussen; Marie Helleberg; Margaret T May; Shoaib Afzal; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Jan Gerstoft; Børge G Nordestgaard; Niels Obel Journal: Clin Infect Dis Date: 2015-01-16 Impact factor: 9.079
Authors: Wajiha Z Akhtar-Khaleel; Robert L Cook; Steven Shoptaw; Pamela Surkan; Ronald Stall; Rebecca J Beyth; Linda A Teplin; Michael Plankey Journal: AIDS Behav Date: 2016-03
Authors: Jonathan P Winickoff; Erica A Healey; Susan Regan; Elyse R Park; Clare Cole; Joan Friebely; Nancy A Rigotti Journal: Pediatrics Date: 2010-02-01 Impact factor: 7.124
Authors: Billy M Tsima; Precious Moedi; Joyce Maunge; Kitso Machangane; Martha Kgogwane; Tebogo Mudojwa; Joseph Bastian; Warren Bilker; Rebecca Ashare; Robert Schnoll; Robert Gross Journal: South Afr J HIV Med Date: 2020-06-24 Impact factor: 2.744
Authors: Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare Journal: J Neuroimmune Pharmacol Date: 2019-12-13 Impact factor: 4.147
Authors: Olufikayo O Bamidele; Trish Green; Sara Tookey; Julie Walabyeki; Una Macleod Journal: Eur J Cancer Care (Engl) Date: 2022-03-15 Impact factor: 2.328
Authors: Titus Josef Brinker; Christian Martin Brieske; Stefan Esser; Joachim Klode; Ute Mons; Anil Batra; Tobias Rüther; Werner Seeger; Alexander H Enk; Christof von Kalle; Carola Berking; Markus V Heppt; Martina V Gatzka; Breno Bernardes-Souza; Richard F Schlenk; Dirk Schadendorf Journal: J Med Internet Res Date: 2018-08-15 Impact factor: 5.428
Authors: Noreen Dadirai Mdege; Fredrick Edward Makumbi; Ronald Ssenyonga; Frances Thirlway; Joseph K B Matovu; Elena Ratschen; Kamran Siddiqi; Kellen Nyamurungi Namusisi Journal: Nicotine Tob Res Date: 2021-06-08 Impact factor: 4.244
Authors: Francisco Cartujano-Barrera; Michelle Lee D'Abundo; Evelyn Arana-Chicas; Surina Chock; Pamela Valera; Charles S Kamen; Ana Paula Cupertino Journal: Int J Environ Res Public Health Date: 2021-03-26 Impact factor: 3.390
Authors: Damon J Vidrine; Thanh C Bui; Michael S Businelle; Ya-Chen Tina Shih; Steven K Sutton; Lokesh Shahani; Diana Stewart Hoover; Kristina Bowles; Jennifer I Vidrine Journal: JMIR Res Protoc Date: 2021-11-17
Authors: James Brown; Christianna Kyriacou; Elisha Pickett; Kelly Edwards; Hemal Joshi; Nafeesah Stewart; Andrew Melville; Margaret Johnson; Jan Flint; Angela Bartley; Alison Rodger; Marc Lipman Journal: BMJ Open Respir Res Date: 2019-10-03